Skip to main content

Table 6 Safety Outcomes

From: Design of the exhale airway stents for emphysema (EASE) trial: an endoscopic procedure for reducing hyperinflation

1 Major hemoptysis: ≥200 mL estimated blood loss or requiring transfusion, or requiring arterial embolization, or surgical/endoscopic intervention
2 Respiratory failure requiring mechanical ventilation ≥24 hours
3 Pulmonary infection or COPD exacerbation requiring hospitalization >7 days
4 Pneumothorax requiring tube drainage >7 days
5 Death within 30 days of device implantation or the initial hospitalization if longer than 30 days, and death from respiratory causes